Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7483-7494
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7483
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7483
Table 2 Results of thyroid function tests on admission and follow-up
| Date | FT3 (3.1-6.8 pmol/L) | FT4 (12-22 pmol/L) | TSH (0.27-4.2 μU/mL) | TGAb (< 115 U/mL) | TPOAb (< 34 U/mL) | TRAb (0-1.75 U/L) |
| October 2020 | 23.28 | 48.61 | < 0.005 | NA | NA | 3.69 |
| November 2020 | 23.46 | 37.15 | < 0.005 | 179.6 | 18.2 | 2.80 |
| 31 December 2020 | 3.97 | 12.66 | 0.28 | NA | NA | NA |
| 09 February 2021 | 4.83 | 14.57 | 1.64 | NA | NA | NA |
| 26 April 2021 | 5.18 | 15.50 | 1.83 | NA | NA | NA |
| 23 July 2021 | 5.82 | 16.80 | 2.66 | NA | NA | NA |
| 15 December 2021 | 6.03 | 16.41 | 1.68 | 24.56 | 25.48 | 1.38 |
- Citation: Qin YZ, Liu YM, Wang Y, You C, Li LN, Zhou XY, Lv WM, Hong SH, Xiao LX. Novel compound heterozygous mutation of SLC12A3 in Gitelman syndrome co-existent with hyperthyroidism: A case report and literature review. World J Clin Cases 2022; 10(21): 7483-7494
- URL: https://www.wjgnet.com/2307-8960/full/v10/i21/7483.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i21.7483